Indication
Cervical High Grade Squamous Intraepithelial Lesion
3 clinical trials
3 products
Clinical trial
Randomized Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSILStatus: Completed, Estimated PCD: 2022-08-23
Product
PlaceboProduct
VGX-3100Clinical trial
A Prospective, Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VGX-3100 Delivered Intramuscularly Followed by Electroporation With CELLECTRA™-5PSP for the Treatment of HPV-16 and/or HPV-18 Related High Grade Squamous Intraepithelial Lesion (HSIL) of the CervixStatus: Completed, Estimated PCD: 2020-07-08
Clinical trial
Predicting Response In Cervical Intraepithelial Neoplasia to Topical Imiquimod TreatmentStatus: Recruiting, Estimated PCD: 2024-12-01
Product
Imiquimod